1.. INTRODUCTION
================

The development of science and technology is not guaranteed the tooth resistance against disease or trauma completely, so there are still many cases of tooth loss. When tooth loss occurs, bone volume will decrease. Bone resorption due to tooth extraction may cause a problem in prosthodontics because it may lead to poor results of long-term treatment ([@ref1]). Within 6 months, bone resorption occurs as much as 1.5-2 mm in vertical direction and 40%-50% in horizontal direction, and most cases occur in the first three months. If the treatment is not taken, the bone resorption can reach 40-60% of bone ridge volume in the first three years ([@ref2]).

At present-day, there are various types of materials and techniques used for bone resorption treatment, including bone graft material, usage of guided tissue regeneration, application of growth factors to stimulate bone regeneration ([@ref3]). Bone graft is used as scaffolds, matrix attachment and proliferation osteoblast ([@ref4]). Bone graft material must have a biocompatibility property with living tissue, profitable for osteoconduction, osteoinduction and has ability to support new bone formation. Graft biocompatibility is very crucial in order to prevent rejection by the host and not toxic to the body ([@ref5], [@ref6]).

The most ideal bone graft to use is an autograft that derived from the patient\'s own body. However, sometimes the process is not able to support, so that autograft is developed to allograft material. Yet, allografts often transmit infectious diseases, especially HIV and for that reason allograft is developed to xenograft material. The most commonly used xenograft is from bovine, but transmission of bovine spongiform encephalitis (BSE) is commonly occur. Various type of synthetic bone grafts was developed to minimize the risk of transmitting disease. Ideal conditions that need to be fulfilled by synthetic bone grafts are biocompatible, profitable for osteoconduction, osteoinduction and osteogenesis. Those three mechanisms are the most important for resorbable biomaterials that support tissue growth ([@ref6]). However, alloplast particles cannot be counted on the site at the location of the embedded graft so that bone formation cannot be determined ([@ref7]).

One type of bone graft, namely hydroxyapatite graft which can be produced from coral reef skeletons, bovine bones, chicken claws, shellfish shells and human cancellous bones ([@ref8]). In Indonesia, natural raw materials, especially those derived from marine biota are easily found, relatively low-cost and the production process is simple. Among these raw materials are crab shells (Portunus pelagicus) which are uncommonly used, even turned into waste ([@ref9]).

A crab shell contains large amounts of calcium carbonate, about 40% - 70% ([@ref9]). Calcium carbonate is source of calcium that can be used as synthesis material of hydroxyapatite. Apatite crystals contain many carbon groups in carbonate shapes. Hydroxyapatite is a stable apatite crystal and implanted as bone replacement or filler. Hydroxyapatite biomaterials consist of bioactive components that are compatible with bones and teeth. This supports the use of crab shells as bone replacement alternative biomaterial based on the chemical composition. In addition, the development of crab shells as hydroxyapatite graft has not been carried out further and still requires biocompatibility test to be used on a wide scale ([@ref10]).

In performing in vitro test of a new materials, fibroblasts are used. Fibroblasts are connective tissue cells that function as defense because they are able to differentiate as odontoblast and osteoblast cells and produce collagen fibers in healing process. The ability to grow fast in tissues and be able to live solitary is the reason why fibroblast cells are easily cultured into cell subjects ([@ref11]). The biocompatibility test of hydroxyapatite graft produced from crab shells on human gingival fibroblast (HGF) cell cultures is required to determine whether the graft is ideal to be applied to the bone.

2.. AIM
=======

In the present study, we determine the biocompatibility of Portunus pelagicus hydroxyapatite graft on human gingival fibroblast cell culture.

3.. METHODS
===========

This is an experimental laboratory research with post-test only control group design. The treatment was carried out by giving hydroxyapatite graft powder from crab shell (Portunus pelagicus) on HGF cell culture. This study used 5 samples for each treatment group, those include the addition of hydroxyapatite graft crab shell at concentration of 100 ppm, 50 ppm and 25 ppm as well as cell control group and media control of 5 samples respectively. The sampling technique used is simple random sampling.

Processing of crab shells (Portunus pelagicus) for the synthesis of hydroxyapatite graft conducted at the Center for Biomaterials of Dr. Soetomo General National Hospital Surabaya. It was began by the washing process of crab shells using distilled water, chlorine and H2O2 then continued with the heating process of crab shells using furnace at 1000°C for 2 hours. Powder sifting process was performed with sifting machine until the particle size was less than 155μm and continued with the characterization of hydroxyapatite compounds using SEM-EDX.

The in vitro study was conducted at Stem Cell Research Development Center of Universitas Airlangga Surabaya. The isolation process of Human Gingival Fibroblast (HGF) cells was conducted from healthy gingival samples patients aged less than 30 years old. HGF cells are processed by splitting process which aim to multiply cells and replace α-MEM media. Before the treatment phase, cell preparations are processed by doing washing for several times using trypsin enzymes and α-MEM. Cells were divided into 96-well microplate as much as 100 μl with density 3-5x103 and incubated for 24 hours at 37°C.

Hydroxyapatite graft powder was diluted with α-MEM media according to the concentration dose, at 100 ppm, 50 ppm and 25 ppm. Each of 5 samples were dripped by hydroxyapatite graft crab shell at concentration of 100 ppm, 50 ppm and 25 ppm. Incubation was carried out for 24 hours then microscopic observation was performed to observe whether cytotoxic effects had occurred. 25μl of MTT was dripped, incubated, then dripped with 10μl of DMSO. The results were analyzed with ELISA reader with wavelength of 620 nm and viability of fibroblast living cells were calculated. The data obtained were tested by Oneway Anova and Post-hoc Tukey HSD.

4.. RESULTS
===========

The results of SEM micrograph was shown on [Figure 1](#figure1){ref-type="fig"}. It showed fineness and homogenity of hydroxyapatite structure. The analysis of the element characerization of the hidroxyapatite graft, the EDX test was conducted and the result shown in [Figure 2](#figure2){ref-type="fig"}. The analysis then described in [Table 1](#table1){ref-type="table"} and showed that the dominant atom in hydroxiapatite graft derived from Portunus pelagicus was O followed by Ca and P.

Optical density (OD) value of formazan hydroxyapatite graft powder from Portunus pelagicus was measured using spectrophotometer. The mean value of formazan optical density in 5 samples for each treatment group and percentage of living cells can be seen in [Table 2](#table2){ref-type="table"}. From the result of MTT assay, it indicated that the treatment at concentrations of 100 ppm and 50 ppm is capable to reduce the number of living cells to a certain extent. The results will be analyzed using the LD50 parameter to assess the biocompatibility of hydroxyapatite graft powder from crab shells from the entire concentration group.

Kolmogorov-Smirnov test results showed that all groups have a normality probability value greater than 0.05 (p\> 0.05) which means that the data was normally distributed. Data analysis was continued by testing the sample variance homogeneity using Levene\'s test. The homogeneity test results indicated the significance value of 0.987 which means the data was homogeneous (p \> 0.05). Data was normally distributed and homogeneous so the data needs to be tested using the Oneway Anova test with Post-Hoc Tukey HSD. Oneway Anova test was conducted to find out the overall difference in the sample group. From the test results shown the value of sig. = 0.752 which means there is no significant difference in the whole group because it had not met the sig requirements (p \<0.05).

5.. DISCUSSION
==============

The results of SEM micrograph was shown on [Figure 1](#figure1){ref-type="fig"}. It showed fineness and homogenity of hydroxyapatite structure. The analysis of the element characerization of the hidroxyapatite graft, the EDX test was conducted and the result shown in [Figure 2](#figure2){ref-type="fig"}. The analysis then described in [Table 1](#table1){ref-type="table"} and showed that the dominant atom in hydroxiapatite graft derived from Portunus pelagicus was O followed by Ca and P.

Optical density (OD) value of formazan hydroxyapatite graft powder from Portunus pelagicus was measured using spectrophotometer. The mean value of formazan optical density in 5 samples for each treatment group and percentage of living cells can be seen in [Table 2](#table2){ref-type="table"}. From the result of MTT assay, it indicated that the treatment at concentrations of 100 ppm and 50 ppm is capable to reduce the number of living cells to a certain extent. The results will be analyzed using the LD50 parameter to assess the biocompatibility of hydroxyapatite graft powder from crab shells from the entire concentration group.

Kolmogorov-Smirnov test results showed that all groups have a normality probability value greater than 0.05 (p\> 0.05) which means that the data was normally distributed. Data analysis was continued by testing the sample variance homogeneity using Levene\'s test. The homogeneity test results indicated the significance value of 0.987 which means the data was homogeneous (p \> 0.05). Data was normally distributed and homogeneous so the data needs to be tested using the Oneway Anova test with Post-Hoc Tukey HSD. Oneway Anova test was conducted to find out the overall difference in the sample group. From the test results shown the value of sig. = 0.752 which means there is no significant difference in the whole group because it had not met the sig requirements (p \<0.05).

6.. CONCLUSION
==============

From the results of this study it can be concluded that hydroxyapatite graft powder from Portunus pelagicus has biocompatible properties on HGF cell culture and at the lowest concentration of 25 ppm has optimal biocompatibility compared to the other two concentrations.
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![SEM micrograph of hydroxyapatite crab shell samples at 500x magnification from two different fields of view](medarch-73-378-g001){#figure1}

![EDX spectrum of hydroxyapatite samples from Portunus pelagicus with three main elements, O, Ca, and P.](medarch-73-378-g002){#figure2}

![Microscopic images of fibroblast cells after hydroxyapatite graft powder exposure at concentration; A) 100 ppm, B) 50 ppm, and C) 25 ppm with 20x magnification.](medarch-73-378-g003){#figure3}

###### Calculation of normalized weight and calculation of atoms in Hydroxyapatite Graft derived from Portunus pelagicus.

  Element   Normalized Weight Calculation (wt.%)   Atom Calculation (at.%)   Standard deviation
  --------- -------------------------------------- ------------------------- --------------------
  O         67,59                                  83,54                     6,9
  Ca        29,16                                  14,39                     0,7
  P         3,25                                   2,08                      0,1

###### The mean value of optical density and the percentage of living cells for each treatment.

  Treatment Group               N   Optical Density Mean   Standard Deviation   Percentage of Living Cells
  ----------------------------- --- ---------------------- -------------------- ----------------------------
  Hydroxyapatite graft 100ppm   5   0,0684                 0,017785             89,8%
  Hydroxyapatite graft 50ppm    5   0,0724                 0,018366             93,27%
  Hydroxyapatite graft 25ppm    5   0,0816                 0,018366             101,2%
  Cell Control                  5   0,0802                 0,014704             100%
  Media Control                 5   0,0358                 0,000837             0%
